This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Kurumi Mineno: Innovator in Heterocyclic Compounds
Introduction
Kurumi Mineno is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of chemistry, particularly in the development of novel heterocyclic compounds. Her work focuses on compounds that have potential therapeutic applications, especially in promoting platelet production.
Latest Patents
Kurumi Mineno holds a patent for a heterocyclic compound that exhibits aryl hydrocarbon receptor antagonist activity. This innovative compound is represented by the general formula [I], where ring A, ring B, R, R, R, R, n, and X are defined in the patent documentation. The compound's unique properties make it a valuable asset in medical research and development.
Career Highlights
Mineno is currently employed at Otsuka Pharmaceutical Company, Limited, where she continues to advance her research in pharmaceutical chemistry. Her dedication to innovation has positioned her as a key figure in her field, contributing to the company's mission of improving health through innovative solutions.
Collaborations
Throughout her career, Kurumi Mineno has collaborated with notable colleagues, including Kazuhiro Ohdachi and Yusuke Fujimori. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.
Conclusion
Kurumi Mineno's work in the field of heterocyclic compounds exemplifies the impact of innovative research in pharmaceuticals. Her contributions not only advance scientific knowledge but also hold promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
